Processa Pharmaceuticals (PCSA) EBITDA Margin Growth (1y) (2013 - 2016)
Processa Pharmaceuticals (PCSA) EBITDA Margin Growth (1y) (2013 - 2016) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 7,666.00 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1,238.00 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2,002.00 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 29,091.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | -1,651.00 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -3,558.00 |
| 10 | Processa Pharmaceuticals | 5.93 Mn | 5.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | -11,109.00 |
| Dec 31, 2015 | 352,363.00 |
| Sep 30, 2015 | 54,783.00 |
| Jun 30, 2015 | -847,579.00 |
| Mar 31, 2015 | 855,604.00 |
| Dec 31, 2014 | -363,360.00 |
| Sep 30, 2014 | -72,202.00 |
| Jun 30, 2014 | -24,618.00 |
| Mar 31, 2014 | -578,276.00 |
| Dec 31, 2013 | 130,971.00 |
| Sep 30, 2013 | 62,237.00 |
| Jun 30, 2013 | -29,499.00 |